Dasotraline: Phase I data

Sumitomo Dainippon’s Sunovion Pharmaceuticals Inc. subsidiary reported data from a double-blind, double-dummy, placebo- and active-controlled, 6-way crossover, Canadian Phase I human abuse liability t...